Benefits of anterior chamber paracentesis in the management of glaucomatous emergencies.

UNLABELLED: Anterior chamber paracentesis (ACP) is an alternative technique to reduce intraocular pressure (IOP) in patients with acute closed-angle glaucoma (ACAG) and requires controlled drainage of aqueous humor from the anterior chamber using a needle or an incision paracentesis with a knife. PURPOSE: Evaluation of efficacy and safety of AC paracentesis in acute increases of intraocular pressure. METHOD: This was an observational study done on a group of 24 patients with acute, unilateral increases of IOP> 50mmHg. IOP was measured before, 10 minutes, 1 day, 7 days and 30 days after ACP using applanation tonometry. RESULTS: Intraocular pressure decreased from an average of 52.5 mmHg to 25.5 mmHg to 17.5 mmHg at 10 minutes and 7 days from the ACP. Anterior chamber paracentesis combined with glaucoma medication led to the cessation of symptoms in all patients included in the lot and the resolution of corneal edema in 20 cases. CONCLUSION: ACP is safe and effective in acute increases of IOP in the acute form of the primary angle closure glaucoma but remains an adjunct to conventional therapy drug.

OCT parameters in patients with diabetic maculopathy.

The treatment of the clinically significant macular edema in patients with diabetic maculopathy by the intravitreal administration of corticosteroids and antiangiogenic factors requires rapid and more accurate investigation methods aimed at following up the dynamic evolution of the structural parameters of the retina. The purpose of the study is to compare the outcome of OCT parameters for each group (Group A treated by intravitreal administered triamcinolone acetonide and Group B treated by intravitreal administered triamcinolone acetonide in combination with bevacizumab). Methods involved the selection of cases, dynamic measurements of the retina structures, so that, at the end, the data from the two groups of patients could be compared. The results showed a positive development in the short and medium term in both groups of patients.

Visual acuity outcome in patients with diabetic maculopathy.

The purpose of this study is to follow up visual acuity in patients diagnosed with clinically significant macular edema and treated by an intravitreal injection of triamcinolone acetonide or in combination with bevacizumab. The working method: based on the selectivity criteria we involved 295 patients (460 eyes), divided into 2 groups according to the treatment administered and one control group. The results showed a better preservation of the functional parameter for the group of patients treated with intravitreal injection of triamcinolone acetonide and bevacizumab.